| Financial Year |
March 31 2023 |
| Monetary Funds |
605,489,879.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
71,915,011.81 |
| Accounts Receivable |
349,617,530.91 |
| Advances to Suppliers |
31,693,041.97 |
| Other Receivables |
24,393,059.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
105,000.00 |
| Dividend Receivable |
-- |
| Inventories |
402,842,860.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,725,722.81 |
| Other Current Assets |
39,651,879.27 |
| Total Current Assets |
1,547,147,503.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
47,417,731.08 |
| Long-term Equity Investment |
10,911,299.65 |
| Investment Properties |
11,296,199.37 |
| Fixed Assetes |
454,899,994.53 |
| Under-construction Projects |
108,300,968.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,826,196.83 |
| R&D expenses |
3,517,415.95 |
| Goodwill |
41,568,481.29 |
| Long-Term Deferred and Prepaid Expenses |
42,601,358.22 |
| Deferred Income Tax Assets |
74,778,152.00 |
| Other Non-Current Assets |
110,880,269.04 |
| Sub-Total of Non-Current Assets |
1,034,134,248.65 |
| Total Assets |
2,581,281,752.03 |
| Short-Term Loans |
754,902,623.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,916,468.80 |
| Accounts Payable |
165,317,154.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,366,359.27 |
| Taxes Payable |
13,882,796.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,250,226.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,530,792.60 |
| Other Current Liabilities |
75,757,396.06 |
| Sub-Total of Current Liabilities |
1,133,699,921.90 |
| Long-term Loans |
123,647,034.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,430,677.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,418,722.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
164,503,268.64 |
| Total Liabilities |
1,298,203,190.54 |
| Paid-In Capital(Or Share Stock) |
457,321,024.00 |
| Capital Surplus |
762,320,889.13 |
| Surplus Reserve |
14,997,318.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-14,397,758.42 |
| Minority Stockholder's Interest |
66,871,416.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,216,207,144.60 |
| Owner's Equity（Stockholder's Equity） |
1,283,078,561.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,581,281,752.03 |
